Suppr超能文献

肠内管饲用于肌萎缩侧索硬化/运动神经元病。

Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

机构信息

Institute of Medical Science, University of Toronto, Toronto, Canada.

Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

出版信息

Cochrane Database Syst Rev. 2023 Aug 10;8(8):CD004030. doi: 10.1002/14651858.CD004030.pub4.

Abstract

BACKGROUND

Maintaining adequate nutrition is critical for people with amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND). Enteral tube feeding is offered to people experiencing difficulty swallowing (dysphagia) to prevent weight loss and aspiration pneumonia. Among the types of enteral tube feeding, percutaneous endoscopic gastrostomy (PEG) is the typical procedure offered to people with ALS and will be mainly discussed here.

OBJECTIVES

To examine the effectiveness of percutaneous endoscopic gastrostomy or other enteral tube feeding in people with ALS, compared to oral feeds without enteral tube feeding on: 1. survival; 2. nutritional status; 3. quality of life. To examine the incidence of minor and major complications of percutaneous endoscopic gastrostomy (PEG) and other enteral tube feeding procedures in people with ALS.

SEARCH METHODS

On 3 January 2020 and 6 February 2021, we searched the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE. Embase, ClinicalTrials.gov and WHO ICTRP. We screened the results to identify randomized controlled studies on enteral tube feeding in ALS. We reviewed all references from the search in published articles to identify any additional references.

SELECTION CRITERIA

We included randomized controlled trials (RCTs), quasi-RCTs, and cross-over trials evaluating the effectiveness and complications of PEG or other enteral tube feeding placement in ALS.

DATA COLLECTION AND ANALYSIS

We used standard methodological procedures expected by Cochrane.

MAIN RESULTS

We found no RCTs or quasi-RCTs comparing the effectiveness of enteral tube feeding versus oral feeds without enteral tube feeding.

AUTHORS' CONCLUSIONS: There are no RCTs or quasi-RCTs to indicate whether enteral tube feeding is effective compared to continuation of oral feeding for any of the outcome measures. Such RCTs are very unlikely to be performed for ethical reasons. RCTs evaluating the effect of different enteral tube insertion techniques and timings of tube placement on survival and quality of life of people with ALS dysphagia are feasible and warranted.

摘要

背景

对于肌萎缩侧索硬化症(ALS)患者(又称运动神经元病(MND)),维持充足的营养至关重要。对有吞咽困难(吞咽障碍)的患者提供肠内管饲,以防止体重下降和吸入性肺炎。在各种肠内管饲中,经皮内镜下胃造口术(PEG)是为 ALS 患者提供的典型手术,这里主要讨论这种手术。

目的

比较经皮内镜下胃造口术或其他肠内管饲与不进行肠内管饲的口服喂养在以下方面的效果:1. 生存率;2. 营养状况;3. 生活质量。观察经皮内镜下胃造口术(PEG)和其他肠内管饲在 ALS 患者中的轻微和严重并发症的发生率。

检索方法

我们于 2020 年 1 月 3 日和 2021 年 2 月 6 日检索了 Cochrane 神经肌肉疾病组专业注册库、CENTRAL、MEDLINE、Embase、ClinicalTrials.gov 和世卫组织国际临床试验注册平台。我们筛选结果以确定关于 ALS 肠内管饲的随机对照研究。我们查阅了从发表文章中检索到的参考文献,以确定任何其他参考文献。

选择标准

我们纳入了评价 PEG 或其他肠内管饲在 ALS 中的有效性和并发症的随机对照试验(RCT)、准 RCT 和交叉试验。

数据收集与分析

我们使用 Cochrane 预期的标准方法学程序。

主要结果

我们未发现比较肠内管饲与不进行肠内管饲的口服喂养的有效性的 RCT 或准 RCT。

作者结论

由于伦理原因,不太可能开展 RCT 或准 RCT 来确定与继续口服喂养相比,肠内管饲在任何结局指标上是否有效。对于有吞咽障碍的 ALS 患者,评估不同肠内管插入技术和管饲时间对生存率和生活质量的影响的 RCT 是可行和有必要的。

相似文献

1
2
Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的肠内管饲喂养
Cochrane Database Syst Rev. 2011 Jan 19;2011(1):CD004030. doi: 10.1002/14651858.CD004030.pub3.
4
Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的对症治疗
Cochrane Database Syst Rev. 2017 Jan 10;1(1):CD011776. doi: 10.1002/14651858.CD011776.pub2.
6
Use of Noninvasive Ventilation During Feeding Tube Placement.在放置饲管期间使用无创通气。
Respir Care. 2017 Nov;62(11):1474-1484. doi: 10.4187/respcare.05031. Epub 2017 Aug 14.
7
Enteral tube feeding for people with severe dementia.经口肠内营养管饲用于重度痴呆患者。
Cochrane Database Syst Rev. 2021 Aug 13;8(8):CD013503. doi: 10.1002/14651858.CD013503.pub2.
10
Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease.肌萎缩侧索硬化症/运动神经元病的机械通气
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD004427. doi: 10.1002/14651858.CD004427.pub4.

引用本文的文献

本文引用的文献

2
Natural history and clinical features of ALS in Malaysia.马来西亚肌萎缩侧索硬化症的自然病史和临床特征。
Amyotroph Lateral Scler Frontotemporal Degener. 2021 Feb;22(1-2):108-116. doi: 10.1080/21678421.2020.1832121. Epub 2020 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验